HIV in Ireland 2017 Provisional Data May 2018

HIV in Ireland, 2017 Provisional data These slides present provisional data on cases of HIV notified to HPSC during 2017 via CIDR. Data will change as further data are received from clinicians (64% of forms received up to 24th April 2018). Notifications of HIV in Ireland include people who were previously diagnosed HIV positive in another country. Following validation of data, more detailed reports on the epidemiology of HIV for 2017 will be produced. You can stay up-to-date with current HIV and STI data with the weekly HIV & STI report. http://www.hpsc.ie/CIDR/ http://www.hpsc.ie/a-z/hivstis/hivandaids/hivdataandreports/ http://www.hpsc.ie/a-z/hivstis/sexuallytransmittedinfections/publications/stireports/stiweeklyreports/

HIV notifications 504 notifications in 2017, very similar to 2016 (n=506) 2017 Provisional Data

HIV notification rate Stable rate from 2015 to 2017 (10.1-10.6 per 100,000 population) 2017 Provisional Data

Regional breakdown Highest rates in HSE East (Dublin, Kildare and Wicklow) compared to all other areas (twice the national rate) 2017 Provisional Data

Age and sex distribution, 2017 Three quarters of notifications in men (n=381) 2017 Provisional Data

Route of transmission Notifications of HIV in 2017 highest in MSM, follows by heterosexuals, and PWID. Transmission route at this stage unknown for 31% of cases. MSM: men who have sex with men; PWID: People who inject drugs; Unknown category includes other 2017 Provisional Data

HIV Prevention and Treatment Get tested for HIV regularly Further information on sexual health services and HIV testing is available at http://www.hse.ie/eng/services/list/5/sexhealth/ (HSE Sexual Health Services) http://www.hivireland.ie/hiv/testing/free-hiv-sti-testing-centre-locator/ (HIV Ireland testing locator) www.man2man.ie (Resource for gay and bisexual men) HIV treatment The HSE recommends that all HIV infected individuals attending HIV services in Ireland are offered antiretroviral therapy as soon as possible and informed of the benefits of antiretroviral therapy in reducing HIV infectiousness and improving their personal health. Further information available at http://www.hpsc.ie/a-z/hivstis/hivandaids/hivtreatmentandprep/ 2017 Provisional Data

Acknowledgements We would like to sincerely thank all of the data providers and all who have contributed to this report including: National Virus Reference Laboratory (NVRL); Microbiology laboratories; Departments of Public Health; Consultants in Infectious Disease/Genitourinary Medicine; Infectious Disease Unit, Our Lady’s Hospital for Children (OLHC), Crumlin for paediatric data; GPs; HIV clinical nurse specialists; Health Advisors; All other clinical staff involved. Non-identifiable HIV data were extracted from CIDR on 24th April 2018, and were correct at the time of publication. These slides may be copied and reproduced, provided HPSC is acknowledged. Suggested citation: HSE-Health Protection Surveillance Centre. HIV provisional slideset 2017. Dublin: HPSC; 2018. 2017 Provisional Data